Ambiente para fazer ci�ncia nos EUA j� n�o � t�o bom, diz Nobel de Medicina

Katalin Karikó, the 71-year-old Hungarian biochemist, highlighted concerns about the diminishing research environment in the U.S. during a press event at the Lindau Nobel Prize meeting in Germany. Her casual attire contrasted with the significance of her statement about the declining conditions for scientific research in the U.S., emphasizing her work on mRNA vaccines. This discussion underscores the broader implications for global medical advancements and the need for supportive research environments to sustain innovation and scientific progress.